chitosan has been researched along with Astrocytoma, Grade IV in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.50) | 29.6817 |
| 2010's | 22 (55.00) | 24.3611 |
| 2020's | 17 (42.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bruinsmann, FA; de Cristo Soares Alves, A; de Fraga Dias, A; Figueiró, F; Lopes Silva, LF; Raffin Pohlmann, A; Sonvico, F; Stanisçuaski Guterres, S; Visioli, F | 1 |
| Bibi, S; Chopra, H; Emran, TB; Mishra, AK; Mohanta, YK; Sharma, R; Singh, I | 1 |
| Abdelhady, HG; Aleanizy, FS; Alqahtani, FY; Alqahtani, QH; Alrfaei, BM; Alsarra, I; Alswailem, R; Badran, M | 1 |
| Ahmad, S; Ansari, MD; Aqil, M; Bano, S; Dar, KI; Emad, NA; Khan, I; Pandit, J; Rizvi, MMA; Sultana, Y | 1 |
| Adams, F; Brameyer, S; Gabold, B; Jung, K; Merdan, T; Merkel, OM; Ried, CL | 1 |
| Abadi, B; Adeli-Sardou, M; Ahmadi-Zeidabadi, M; Ameri, A; Amirinejad, M; Forootanfar, H; Khazaeli, P; Nokhodchi, A; Ranjbar, M | 1 |
| Barbosa, HFG; de Lima, SCG; de Souza, LEB; Matsuo, FS; Osako, MK; Piva, HL; Tedesco, AC | 1 |
| Abolfathi, S; Zare, M | 1 |
| Ghahremanloo, A; Ghoreyshi, N; Hashemy, SI; Homayouni Tabrizi, M; Javid, H | 1 |
| Baltazar, F; Boni, FI; Ferreira, LMB; Ferreira, NN; Granja, S; Gremião, MPD; Reis, RM | 1 |
| Ammendola, M; Bajek, A; Balik, K; Garcia-Valls, R; Giamberini, M; Haponska, M; Kazmierski, L; Kozlowska, J; Lis, A; Matulewicz, K; Modrakowska, P; Tylkowski, B | 1 |
| Barathikannan, K; Gopi, M; Jayalakshmi, J; Kalaichelvan, PT; Saravanakumar, K; Sathiyaseelan, A; Shajahan, A; Wang, MH | 1 |
| Baltazar, F; Boni, FI; Cury, BSF; Ferreira, LMB; Ferreira, NN; Granja, S; Gremião, MPD; Prezotti, FG; Reis, RM | 1 |
| Bazzazzadeh, A; Dizaji, BF; Irani, M; Kianinejad, N; Nouri, A | 1 |
| Chan, LY; Chen, JP; Chuang, CC; Hsu, PW; Lan, YH; Lu, WT; Lu, YJ | 1 |
| Bae, Y; Choi, JS; Huh, KM; Joo, C; Kang, SW; Park, KH | 1 |
| Li, L; Lu, Z; Song, N; Song, P; Wu, M; Zhao, X | 1 |
| Chang, FC; Erickson, AE; Lan Levengood, SK; Sun, J; Zhang, M | 1 |
| Abbasi, B; Daroudi, M; Gholami, L; Kazemi Oskuee, R; Tafaghodi, M | 1 |
| Lakkadwala, S; Singh, J | 1 |
| Jeong, TH; Kang, JH; Ko, YT; Ramalingam, P; Turabee, MH | 1 |
| Battogtokh, G; Gotov, O; Hong, EJ; Kang, JH; Ko, YT; Shim, MS; Shin, D | 1 |
| Afjei, R; Babikir, HA; Bose, RJC; Chang, E; Gambhir, SS; Habte, F; Malhotra, M; Massoud, TF; Paulmurugan, R; Robinson, E; Sinclair, R; Sukumar, UK; Zeng, Y | 1 |
| Cooper, A; Edmondson, D; Ellenbogen, RG; Jana, S; Kievit, FM; Lee, JS; Leung, MC; Wang, K; Wood, D; Zhang, M | 1 |
| Chattopadhyay, A; Chockalingam, S; Ghosh, SS; Sanpui, P; Sharma, S | 1 |
| Florczyk, SJ; Jana, S; Kievit, FM; Sham, J; Sytsma, SK; Wang, K; Wood, DL; Zhang, M | 1 |
| Benoit, JP; Boesen, K; Lagarce, F; Messaoudi, K; Saulnier, P | 1 |
| Ellenbogen, RG; Erickson, AE; Jensen, MC; Kievit, FM; Ravanpay, A; Tsao, CT; Zhang, M | 1 |
| Çakmak, AS; Gümüşderelioğlu, M; Kutlu, C | 1 |
| Ellenbogen, RG; Florczyk, SJ; Kievit, FM; Lee, JS; Leung, MC; Silber, JR; Wang, K; Wu, JD; Zhang, M | 1 |
| Benoit, JP; Danhier, F; Lagarce, F; Lemaire, L; Messaoudi, K | 1 |
| Cheng, HL; Lu, HC; Ma, J; Shi, JX; Zhang, Y; Zhuang, Z | 1 |
| Fan, L; He, J; Qiao, Y; Tan, J; Wang, Q; Wu, H; Yang, Q; Zhang, Y | 1 |
| Benoit, JP; Couez, D; Franconi, F; Lemaire, L; Lollo, G; Ullio-Gamboa, G; Vincent, M | 1 |
| Ellenbogen, RG; Jeon, M; Kievit, FM; Silber, JR; Wang, K; Zhang, M | 1 |
| Ellenbogen, RG; Erickson, AE; Kievit, FM; Lan Levengood, SK; Wang, K; Zhang, M | 1 |
| Amighi, K; De Vleeschouwer, S; Dilissen, E; Gerhardt, H; Kiss, R; Lefranc, F; Mathieu, V; Mathivet, T; Rosière, R; Steelant, B; Van Gool, SW; Van Woensel, M; Wauthoz, N | 1 |
| Du, L; Li, F; Tang, XJ; Wang, G; Wang, JJ | 1 |
| Ellenbogen, RG; Erickson, AE; Kievit, FM; Silber, JR; Wang, K; Zhang, M | 1 |
| Jon, S; Kim, H; Lee, E; Lee, IH | 1 |
40 other study(ies) available for chitosan and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
Topics: Administration, Intranasal; Animals; Brain; Cell Line, Tumor; Chitosan; Glioblastoma; Lipids; Nanocapsules; Rats; Simvastatin | 2022 |
Nano-chitosan: A novel material for glioblastoma treatment.
Topics: Chitosan; Glioblastoma; Humans | 2022 |
MicroRNA-219 loaded chitosan nanoparticles for treatment of glioblastoma.
Topics: Chitosan; Drug Carriers; Glioblastoma; Humans; MicroRNAs; Nanoparticles | 2022 |
Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.
Topics: Administration, Intranasal; Animals; Brain; Carmustine; Chitosan; Drug Carriers; Drug Delivery Systems; Glioblastoma; Nanoparticles; Particle Size; Rats; Rats, Wistar | 2022 |
Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins.
Topics: Brain; Chitosan; Drug Delivery Systems; Glioblastoma; Humans; Ligands; Nanoparticles; Transferrin | 2023 |
Chitosan-sialic acid nanoparticles of selenium: Statistical optimization of production, characterization, and assessment of cytotoxic effects against two human glioblastoma cell lines.
Topics: Antineoplastic Agents; Cell Line; Chitosan; Glioblastoma; Humans; N-Acetylneuraminic Acid; Nanoparticles; Selenium | 2023 |
Hybrid lipid-biopolymer nanocarrier as a strategy for GBM photodynamic therapy (PDT).
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Glioblastoma; Lipids; Mice; Nanoparticles; Photochemotherapy; Photosensitizing Agents | 2023 |
The evaluation of chitosan hydrogel based curcumin effect on DNMT1, DNMT3A, DNMT3B, MEG3, HOTAIR gene expression in glioblastoma cell line.
Topics: Cell Line, Tumor; Chitosan; Curcumin; DNA Modification Methylases; Gene Expression; Glioblastoma; Humans; Hydrogels | 2023 |
Effect of folic acid-linked chitosan-coated PLGA-based curcumin nanoparticles on the redox system of glioblastoma cancer cells.
Topics: Antioxidants; Catalase; Chitosan; Curcumin; Folic Acid; Glioblastoma; Glutaredoxins; Nanoparticles; Oxidation-Reduction; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Superoxide Dismutase; Thioredoxins | 2023 |
A novel strategy for glioblastoma treatment combining alpha-cyano-4-hydroxycinnamic acid with cetuximab using nanotechnology-based delivery systems.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cetuximab; Chitosan; Coumaric Acids; Drug Combinations; Drug Compounding; Drug Synergism; Glioblastoma; Humans; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer | 2020 |
Stability and anti-proliferative properties of biologically active compounds extracted from Cistus L. after sterilization treatments.
Topics: Capsules; Cell Line, Tumor; Cell Proliferation; Chitosan; Cistus; Flavonoids; Glioblastoma; Humans; Plant Extracts; Polyphenols; Sterilization | 2020 |
Trigonelline-loaded chitosan nanoparticles prompted antitumor activity on glioma cells and biocompatibility with pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Carriers; Drug Liberation; Flow Cytometry; Glioblastoma; Glioma; Materials Testing; Microscopy, Fluorescence; Nanoparticles; Particle Size; Pheochromocytoma; Rats | 2020 |
Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
Topics: Administration, Intranasal; Brain; Cell Line, Tumor; Chitosan; Glioblastoma; Humans; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer | 2020 |
Fabrication of poly(acrylic acid) grafted-chitosan/polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells.
Topics: Acrylic Resins; Cell Line, Tumor; Chitosan; Glioblastoma; Humans; Magnetic Phenomena; Metal-Organic Frameworks; Nanofibers; Paclitaxel; Polyurethanes; Temozolomide | 2020 |
Injectable Thermo-Sensitive Chitosan Hydrogel Containing CPT-11-Loaded EGFR-Targeted Graphene Oxide and SLP2 shRNA for Localized Drug/Gene Delivery in Glioblastoma Therapy.
Topics: Blood Proteins; Cell Line, Tumor; Chitosan; Drug Delivery Systems; ErbB Receptors; Gene Transfer Techniques; Glioblastoma; Graphite; Humans; Hydrogels; Irinotecan; Membrane Proteins; Neoplasm Proteins; RNA, Small Interfering | 2020 |
Preparation and characterization of 3D human glioblastoma spheroids using an N-octanoyl glycol chitosan hydrogel.
Topics: 1-Octanol; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Doxorubicin; Drug Evaluation, Preclinical; Glioblastoma; Humans; Hydrogels; Spheroids, Cellular | 2021 |
Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Glioblastoma; Humans; Hydrogen-Ion Concentration; Nanogels; Peptides; Tumor Microenvironment | 2021 |
Fabrication and Characterization of Chitosan-Hyaluronic Acid Scaffolds with Varying Stiffness for Glioblastoma Cell Culture.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Glioblastoma; Humans; Hyaluronic Acid; Temozolomide; Tissue Scaffolds; Tumor Microenvironment | 2018 |
Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Contrast Media; Doxorubicin; Drug Carriers; Drug Liberation; Endocytosis; Glioblastoma; Magnetic Resonance Imaging; Magnetite Nanoparticles; Predictive Value of Tests; Rats; Theranostic Nanomedicine | 2019 |
Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Chitosan; Doxorubicin; Drug Delivery Systems; Endothelial Cells; Erlotinib Hydrochloride; Glioblastoma; Humans; Liposomes; Models, Biological; Neuroglia; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Binding; Receptors, Transferrin; Tissue Scaffolds; Transferrin | 2019 |
N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Hydrogels; Hydrogen-Ion Concentration; Male; Mice, Inbred BALB C; Mice, Nude; Poloxamer; Taxoids | 2019 |
Glycol chitosan-coated near-infrared photosensitizer-encapsulated gold nanocages for glioblastoma phototherapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Endocytosis; Glioblastoma; Gold; Humans; Infrared Rays; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Peptides; Photosensitizing Agents; Phototherapy; Proton Magnetic Resonance Spectroscopy; Tissue Distribution | 2019 |
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Resistance, Neoplasm; Ferric Compounds; Glioblastoma; Gold; Humans; Mice; MicroRNAs; Temozolomide; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2019 |
Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.
Topics: Cell Division; Cell Line, Tumor; Cell Movement; Cell Shape; Chitosan; Gene Expression; Glioblastoma; Humans; Nanofibers; Polyesters | 2013 |
Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells.
Topics: Alginates; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Chitosan; DNA Damage; Glioblastoma; Glucuronic Acid; Hexuronic Acids; Humans; Matrix Metalloproteinases; Metal Nanoparticles; Microscopy, Electron, Scanning; Nanocomposites; Reactive Oxygen Species; Silver | 2014 |
Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM.
Topics: Cell Line, Tumor; Cell Proliferation; Chitosan; Extracellular Matrix; Glioblastoma; Humans; Hyaluronic Acid; Microscopy, Electron, Scanning; Porosity; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds | 2013 |
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
Topics: Acylation; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Synergism; ErbB Receptors; Gene Silencing; Glioblastoma; Humans; Lipids; Nanocapsules; Particle Size; RNA, Small Interfering; Temozolomide; Treatment Outcome | 2014 |
Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chitosan; Culture Media; Cytotoxicity, Immunologic; Glioblastoma; Humans; Hydrogels; Immunotherapy, Adoptive; Polyethylene Glycols; T-Lymphocytes; Tissue Scaffolds; Transition Temperature | 2014 |
Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study.
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Fluorouracil; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2014 |
Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds.
Topics: Alginates; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitosan; Epithelial-Mesenchymal Transition; Glioblastoma; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Nude; Microscopy, Electron, Scanning; Neoplastic Stem Cells; Tissue Scaffolds; Xenograft Model Antitumor Assays | 2014 |
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Galectin 1; Gene Silencing; Glioblastoma; Humans; Lipids; Mice, Nude; Nanocapsules; RNA, Small Interfering; Temozolomide; Tumor Burden | 2015 |
Retinoic acid‑incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells.
Topics: Adult; Antineoplastic Agents; Apoptosis; Brain; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chitosan; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Glioblastoma; Humans; Nanoparticles; Polycomb Repressive Complex 2; Tretinoin | 2015 |
Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Dacarbazine; Delayed-Action Preparations; Drug Delivery Systems; Fatty Acids; Female; Glioblastoma; Gold Compounds; Humans; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanogels; Polyethylene Glycols; Polyethyleneimine; Sulfhydryl Compounds; Temozolomide; Xenograft Model Antitumor Assays | 2015 |
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chitosan; Drug Screening Assays, Antitumor; Drug Stability; Female; Glioblastoma; Lipids; Magnetic Resonance Imaging; Mice; Nanocapsules; Oligodeoxyribonucleotides; Paclitaxel | 2015 |
Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Chitosan; Female; Genetic Therapy; Glioblastoma; Half-Life; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Plasmids; Polyethylene Glycols; Polyethyleneimine; Scorpion Venoms; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells.
Topics: Alginates; Cell Line, Tumor; Chitosan; Extracellular Matrix; Glioblastoma; Glucuronic Acid; Hexuronic Acids; Humans; Neoplastic Stem Cells; Porosity; Tissue Engineering; Tissue Scaffolds; Tumor Microenvironment | 2016 |
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
Topics: Administration, Intranasal; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Galectin 1; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Nanoparticles; RNA, Small Interfering; RNAi Therapeutics | 2016 |
In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Flavonoids; Glioblastoma; Mice; Micelles; Poloxamer; Tissue Distribution | 2016 |
Culture on 3D Chitosan-Hyaluronic Acid Scaffolds Enhances Stem Cell Marker Expression and Drug Resistance in Human Glioblastoma Cancer Stem Cells.
Topics: Biomarkers, Tumor; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glioblastoma; Humans; Hyaluronic Acid; Neoplastic Stem Cells; Phenotype; Tissue Scaffolds | 2016 |
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Topics: Adhesiveness; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Glioblastoma; Half-Life; Humans; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Solubility; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |